These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 15543503)

  • 41. Respiratory complications of the muscular dystrophies.
    Simonds AK
    Semin Respir Crit Care Med; 2002 Jun; 23(3):231-8. PubMed ID: 16088615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA diagnostic tests in Xp21 dystrophy families for prenatal diagnosis.
    Dinçer P; Topaloğlu H; Ayter S
    Turk J Pediatr; 1998; 40(3):347-55. PubMed ID: 9763898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Muscular dystrophies with dystrophin glycoprotein complex deficit].
    Dorobek M
    Neurol Neurochir Pol; 1999; 33(6):1381-9. PubMed ID: 10791040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current diagnosis in muscular dystrophies. New developments, methods of examination and case examples].
    Weilbach FX; Kress W; Strassburg HM; Müller CR; Gold R
    Nervenarzt; 1999 Feb; 70(2):89-100. PubMed ID: 10098143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal diagnosis of congenital myopathies and muscular dystrophies.
    Massalska D; Zimowski JG; Bijok J; Kucińska-Chahwan A; Łusakowska A; Jakiel G; Roszkowski T
    Clin Genet; 2016 Sep; 90(3):199-210. PubMed ID: 27197572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities.
    Guglieri M; Magri F; Comi GP
    Clin Chim Acta; 2005 Nov; 361(1-2):54-79. PubMed ID: 16002060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
    Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
    Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anesthesia preoperative preparation of muscular dystrophy].
    Yamauchi H; Sobue K
    Masui; 2010 Sep; 59(9):1093-5. PubMed ID: 20857662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is muscular dystrophy? Forty years of progressive ignorance.
    Dubowitz V
    J R Coll Physicians Lond; 2000; 34(5):464-8. PubMed ID: 11077661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscular dystrophies and other genetic myopathies.
    Shieh PB
    Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
    Toda T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex.
    MacLeod H; Pytel P; Wollmann R; Chelmicka-Schorr E; Silver K; Anderson RB; Waggoner D; McNally EM
    Neuromuscul Disord; 2007 Apr; 17(4):285-9. PubMed ID: 17336067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nondystrophinopathic muscular dystrophies including myotonic dystrophy.
    Nonaka I; Kobayashi O; Osari S
    Semin Pediatr Neurol; 1996 Jun; 3(2):110-21. PubMed ID: 8795845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiomyopathy in muscular dystrophies.
    Muntoni F
    Curr Opin Neurol; 2003 Oct; 16(5):577-83. PubMed ID: 14501841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene].
    Lesca G; Testard H; Streichenberger N; Pelissier JF; Lestra C; Burel E; Jonveaux P; Michel-Calemard L
    Arch Pediatr; 2007 Mar; 14(3):262-5. PubMed ID: 17258443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progressive muscular dystrophies.
    Chelly J; Desguerre I
    Handb Clin Neurol; 2013; 113():1343-66. PubMed ID: 23622359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continued need for caution in the diagnosis of Duchenne muscular dystrophy.
    Griggs RC; Bushby K
    Neurology; 2005 May; 64(9):1498-9. PubMed ID: 15883307
    [No Abstract]   [Full Text] [Related]  

  • 60. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
    Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP
    Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.